AKT1 and cancer: Because aberrant activation of cell motility pathways may underlie the variety in cancer cell invasion, the elucidation of mechanisms underlying ELMO1 pY724-mediated promotion in Rac activity might establish these molecules as potential targets for effective cancer therapies.